Concepedia

Author

Desiré Kabamba

University Teaching Hospital

Also Known As

D Kabamba, D. Kabamba, Desire Kabamba, Desiré Kabamba

13

Publications

260

Citations

9

H-Index

11

Concepts

All Affiliations

University Teaching HospitalRadboud University NijmegenMedical Research CouncilRadboud University Medical CenterMRC Clinical Trials Unit at UCL
DK

About

Desiré Kabamba is an author at University Teaching Hospital specializing in pharmacodynamic modeling, pharmacoepidemiology, and epidemiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

11

2

Epidemiology

1

1

11

3

Pharmacology

1

1

11

4

Pharmacodynamic Modeling

1

1

11

5

Pharmacokinetic Modeling

1

1

11

Desiré Kabamba

×

9

Publications

259

Citations

9

H-Index

YearCitations

The Impact of Daily Cotrimoxazole Prophylaxis and Antiretroviral Therapy on Mortality and Hospital Admissions in HIV-Infected Zambian Children

A. Sarah Walker, Veronica Mulenga, Deborah Ford,

Clinical Infectious Diseases

2007

63

Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tablets

Rafaëlla FA L'homme, Desiré Kabamba, Fiona M Ewings,

AIDS

2008

56

Strategies for Nevirapine Initiation in HIV‐Infected Children Taking Pediatric Fixed‐Dose Combination “Baby Pills” in Zambia: A Randomized Controlled Trial

Veronica Mulenga, Adrian Cook, A Sarah Walker,

Clinical Infectious Diseases

2010

35

Nevirapine Exposure with WHO Pediatric Weight Band Dosing: Enhanced Therapeutic Concentrations Predicted Based on Extensive International Pharmacokinetic Experience

Mina Nikanjam, Desiré Kabamba, Tim R. Cressey,

Antimicrobial Agents and Chemotherapy

2012

24

Drug Resistance in Human Immunodeficiency Virus Type-1 Infected Zambian Children Using Adult Fixed Dose Combination Stavudine, Lamivudine, and Nevirapine

Ravindra K. Gupta, Deborah Ford, Veronica Mulenga,

The Pediatric Infectious Disease Journal

2010

23

Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tablets

Quirine Fillekes, Veronica Mulenga, Desiré Kabamba,

AIDS

2012

18

Is nevirapine dose-escalation appropriate in young, African, HIV-infected children?

Quirine Fillekes, Veronica Mulenga, Desiré Kabamba,

AIDS

2013

16

The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domains

Jean L. Mbisa, Ravindra K. Gupta, Desiré Kabamba,

Retrovirology

2011

13

Limited Sampling Models to Predict the Pharmacokinetics of Nevirapine, Stavudine, and Lamivudine in HIV-Infected Children Treated With Pediatric Fixed-Dose Combination Tablets

David M. Burger, Fiona M Ewings, Desiré Kabamba,

Therapeutic Drug Monitoring

2010

11

Page 1